Connection
Anna Radominska-Pandya to Metabolic Detoxication, Phase II
This is a "connection" page, showing publications Anna Radominska-Pandya has written about Metabolic Detoxication, Phase II.
|
|
Connection Strength |
|
 |
|
 |
|
0.546 |
|
|
|
-
Radominska-Pandya A. Preface. Drug Metab Rev. 2010 Feb; 42(1):1-2.
Score: 0.351
-
Brents LK, Medina-Bolivar F, Seely KA, Nair V, Bratton SM, Nopo-Olazabal L, Patel RY, Liu H, Doerksen RJ, Prather PL, Radominska-Pandya A. Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors. Xenobiotica. 2012 Feb; 42(2):139-56.
Score: 0.098
-
Chimalakonda KC, Bratton SM, Le VH, Yiew KH, Dineva A, Moran CL, James LP, Moran JH, Radominska-Pandya A. Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltransferases. Drug Metab Dispos. 2011 Oct; 39(10):1967-76.
Score: 0.097